Highlights
A collection of news and information related to Genentech Inc. published by this site and its partners.
Displaying items 1-12 of 62
» View ky3.com items only
1
2
3
4
5
6
Next >
-
BRIEF: Event features stroke information
The Record, Stockton, Calif.Find out about the signs of stroke from 10 a.m. to 4 p.m. Thursday at the WorkNet Building, 56 S. Lincoln St. The event, sponsored by Stockton nonprofit Healings in Motion and Genentech, is free but requires an RSVP. It will include screenings for...Tags: Physical Conditions
-
DEALTALK-Novartis' Vasella exit opens door to Roche stake sale
Reuters* Novartis' one-third stake in Roche built up under Vasella * Vasella exit, retirement of Roche chairman could thaw relations * Roche seen as most likely buyer for the stake * Could make offer in second half of this year - analyst By Caroline...Tags: Shareholders, Voting, Politics, Parties and Movements, Zurich (Swiss Confederation)
-
FDA approves Roche diagnostic for gene mutation in lung cancer
ReutersMay 14 (Reuters) - U.S. health regulators on Tuesday approved a test developed by Roche for a specific gene mutation present in about 10 percent of non-small cell lung cancers, and said the company's drug Tarceva could be used as an initial treatment in...Tags: Medical Procedures and Tests, Roche Holding AG, Health Treatments, Chemotherapy, Food and Drug Administration
-
Bill would regulate 'biosimilar' drugs
SACRAMENTO — Two of the nation's largest biotech companies — Amgen Inc. of Thousand Oaks and Genentech Inc. of South San Francisco — are fighting in Sacramento to keep a tight grip on some of their most lucrative drugs. At stake is a...
Tags: Amgen Inc., Jerry Hill, Pharmaceuticals, Chemical Industry, Roche Holding AG
-
International consortium releases hepatitis C data
Two antiviral drugs used to treat hepatitis C appear to work as well in the real world as they did during clinical trials, an international research consortium has observed. The consortium also released data that may help inform how doctors and patients...Tags: Liver Failure, University of North Carolina at Chapel Hill, Medical Research, University of Chicago, Food and Drug Administration
-
Passenger on flight out of Philly detained for not flushing toilet
PHILADELPHIA — A passenger who flew from Philadelphia to San Francisco was detained on arrival by federal agents after a vindictive flight attendant claimed he had not flushed a lavatory toilet, according to a federal suit. The suit, which seeks...Tags: FBI, Virgin Group, Ltd.
-
Strategies for cutting the cost of prescription drugs
When Maggie Heim had a recurrence of ovarian cancer about a year after her initial treatment, her oncologist suggested that she take what he believed could be a lifesaving drug. There was just one problem: Her insurer wouldn't pay for it. The 59-year-...
Tags: Government Health Care, Employment, Employment Opportunities, Herceptin (drug), Prescription Drugs
-
HIV vaccine trial shut down
In another major setback for efforts to develop an HIV vaccine, federal researchers have shut down a key clinical trial after an independent panel of safety experts determined that volunteers who got an experimental vaccine appeared to be slightly more...Tags: Vaccines, Placebo, Genetic Engineering, Columbia University, Medical Research
-
Boeing, billionaire Penny Pritzker among Obama's donors
Tribune reporterIllinois donors to President Barack Obama’s second inauguration included aviation giant Boeing Co., which contributed $1 million, and billionaire Penny Pritzker, who gave $250,000, according to newly filed records. Pritzker, who is being vetted by...Tags: Federal Election Commission, Finance, Bank of America Corp., Restaurant and Catering Industry, Economy, Business and Finance
-
Major corporations backed inaugural festivities
WASHINGTON — President Obama's second inaugural committee raised a little more than $43 million to put on the official festivities surrounding his January swearing-in, backed by major donations from some of the country's biggest corporations,...Tags: Federal Election Commission, Finance, Bank of America Corp., Economy, Business and Finance, Politics
-
Almost one-third of chemotherapy used 'off-label'
ReutersNEW YORK (Reuters Health) - About one-third of chemotherapies are used to fight cancers that drug regulators never approved them to treat, says a new study. Chemotherapies - drugs that kill rapidly dividing cells - are approved by the Food and Drug...Tags: Medical Research, Health Treatments, Bevacizumab (drug), University of Chicago, Oncology
-
Remove Medicare's straitjacket
Now that the budget "sequester" is in effect, Congress is shifting its attention to entitlement reform. There's simply no way to achieve long-term reductions in federal spending without touching the big health programs, particularly Medicare. Although...
Tags: Government Health Care, Paul Ryan, Bevacizumab (drug), Chemical Industry, Private Health Care
May 18, 2013
|Story| McClatchy-Tribune
May 16, 2013
|Story| Reuters
May 14, 2013
|Story| Reuters
May 12, 2013
|Story| Los Angeles Times
May 2, 2013
|Story| South Florida Sun-Sentinel
Apr 29, 2013
|Story| Allentown Morning Call
Apr 19, 2013
|Story| Los Angeles Times
Apr 25, 2013
|Story| Los Angeles Times
Apr 24, 2013
|Story| Chicago Tribune
Apr 22, 2013
|Story| Los Angeles Times
Feb 19, 2013
|Story| Reuters
Mar 29, 2013
|Story| Los Angeles Times
Original site for Genentech Inc. topic gallery.